Form 4: Zomedica Corp. Executive Karen DeHaan-Fullerton Reports Acquisition of Common Stock

Karen DeHaan-Fullerton, General Counsel/Corporate Secretary of Zomedica Corp., reports acquiring 104,300 shares of common stock at $0.048 per share on May 19, 2025.

Summary

• On May 19, 2025, Karen DeHaan-Fullerton, the General Counsel/Corporate Secretary of Zomedica Corp., acquired 104,300 shares of the company's common stock.
• The shares were purchased at a price of $0.048 per share.
• Following this transaction, Ms. DeHaan-Fullerton beneficially owns 104,300 shares of Zomedica Corp.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. An insider purchase is generally viewed favorably, but the magnitude and specific context need to be considered.

Positives

• An officer purchasing shares can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider trading activity is always closely watched by investors as it can provide insights into the sentiment of company executives regarding the company's prospects. This purchase by the General Counsel could be interpreted as a positive sign.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Zomedica Corp., Karen DeHaan-Fullerton, insider trading, Form 4, common stock, acquisition